(2) SDF1-α in combination with circulating EPCs and SDF1-α with sVEGFR1 has strong prognostic value for predicting breast cancer recurrence and may be helpful in identifying patients at increased risk of disease relapse, who require more aggressive approaches to therapy. Here, CXCL12 is linked to breast cancer.